AstraZeneca таки всё. Тем, кто еще не успел уколоться ей второй раз, официально рекомендовано перейти на одну из mRNA вакцин (Pfizer, Moderna) из-за опасности тромбоза и сомнений в эффективности.
https://www.ctvnews.ca/health/coronavir ... -1.5475020
OTTAWA -- The National Advisory Committee on Immunization (NACI) is now recommending that people who received a first dose of the Oxford-AstraZeneca vaccine receive a second dose of an mRNA vaccine, such as Pfizer-BioNTech or Moderna.
NACI’s latest advice takes into consideration the most recent evidence on the rare instances of blood clots associated with the AstraZeneca shot and the increase of mRNA vaccine supply arriving on Canadian soil.
It also says it reviewed emerging evidence “suggesting better immune responses” when an individual receives a first dose of AstraZeneca and a second dose of an mRNA vaccine.
tss писал(а): ↑19 июн 2021, 20:26
AstraZeneca таки всё. Тем, кто еще не успел уколоться ей второй раз, официально рекомендовано перейти на одну из mRNA вакцин (Pfizer, Moderna) из-за опасности тромбоза и сомнений в эффективности.
https://www.ctvnews.ca/health/coronavir ... -1.5475020
OTTAWA -- The National Advisory Committee on Immunization (NACI) is now recommending that people who received a first dose of the Oxford-AstraZeneca vaccine receive a second dose of an mRNA vaccine, such as Pfizer-BioNTech or Moderna.
NACI’s latest advice takes into consideration the most recent evidence on the rare instances of blood clots associated with the AstraZeneca shot and the increase of mRNA vaccine supply arriving on Canadian soil.
It also says it reviewed emerging evidence “suggesting better immune responses” when an individual receives a first dose of AstraZeneca and a second dose of an mRNA vaccine.
Прошло совсем немного времени и наука доказала. А нам тут с умным видом говорили, что умирают не от астраценики, а случайно.
tss писал(а): ↑19 июн 2021, 20:26
AstraZeneca таки всё. Тем, кто еще не успел уколоться ей второй раз, официально рекомендовано перейти на одну из mRNA вакцин (Pfizer, Moderna) из-за опасности тромбоза и сомнений в эффективности.
https://www.ctvnews.ca/health/coronavir ... -1.5475020
OTTAWA -- The National Advisory Committee on Immunization (NACI) is now recommending that people who received a first dose of the Oxford-AstraZeneca vaccine receive a second dose of an mRNA vaccine, such as Pfizer-BioNTech or Moderna.
NACI’s latest advice takes into consideration the most recent evidence on the rare instances of blood clots associated with the AstraZeneca shot and the increase of mRNA vaccine supply arriving on Canadian soil.
It also says it reviewed emerging evidence “suggesting better immune responses” when an individual receives a first dose of AstraZeneca and a second dose of an mRNA vaccine.
Прошло совсем немного времени и наука доказала. А нам тут с умным видом говорили, что умирают не от астраценики, а случайно.
Теперь случайно мона будет получить инфаркт от ПфайзаДерны.
tss писал(а): ↑19 июн 2021, 20:26
AstraZeneca таки всё. Тем, кто еще не успел уколоться ей второй раз, официально рекомендовано перейти на одну из mRNA вакцин (Pfizer, Moderna) из-за опасности тромбоза и сомнений в эффективности.
https://www.ctvnews.ca/health/coronavir ... -1.5475020
OTTAWA -- The National Advisory Committee on Immunization (NACI) is now recommending that people who received a first dose of the Oxford-AstraZeneca vaccine receive a second dose of an mRNA vaccine, such as Pfizer-BioNTech or Moderna.
NACI’s latest advice takes into consideration the most recent evidence on the rare instances of blood clots associated with the AstraZeneca shot and the increase of mRNA vaccine supply arriving on Canadian soil.
It also says it reviewed emerging evidence “suggesting better immune responses” when an individual receives a first dose of AstraZeneca and a second dose of an mRNA vaccine.
Прошло совсем немного времени и наука доказала. А нам тут с умным видом говорили, что умирают не от астраценики, а случайно.
Теперь случайно мона будет получить инфаркт от ПфайзаДерны.
Через полгода могут сказать, ой, бустер - вторую вакцину не необязательно было делать
Reuters AstraZeneca antibody cocktail fails to prevent COVID-19 in large trial
By Vishwadha Chander and Ludwig Burger
(Reuters) - AstraZeneca said on Tuesday a late-stage trial failed to provide evidence that its COVID-19 antibody therapy protected people who had contact with an infected person from the disease, a small setback in its efforts to find alternatives to vaccines.
The study assessed whether the therapy, a cocktail of two types of antibodies, could prevent adults who had been exposed to the virus in the past eight days from developing COVID-19 symptoms.